599
Views
5
CrossRef citations to date
0
Altmetric
Articles

Assessment of structural and cytotoxic properties of cobalt ferrite nanoparticles for biomedical applications

ORCID Icon, , &
Pages 57-62 | Received 22 Jul 2020, Accepted 01 Dec 2020, Published online: 17 Dec 2020
 

Abstract

Cobalt ferrite (CoFe2O4) has numerous desirable features such as high anisotropy, good magnetic saturation, large coercivity and high mechanical strength. These remarkable characteristics provide extensive employment for their wide application from industrial to biomedical. The present study aims to evaluate the crystal properties, particle size, and morphology of CoFe2O4 nanoparticles prepared by the thermal treatment method and investigates their biocompatibility. XRD and FTIR analyses demonstrated that CoFe2O4 nanoparticles have an inverse cubic spinel crystalline structure. The average size of spherical CoFe2O4 nanoparticles was confirmed by SEM analysis as 58 nm. The cytotoxic effect of CoFe2O4 nanoparticles was evaluated in L929 cells by using the XTT cell viability assay. After 24 h treatment of CoFe2O4 nanoparticles with a concentration between 10 and 1000 µg/ml, the viability of L929 cells did not significantly decrease. It is concluded that growth CoFe2O4 nanoparticles are beneficial materials for use in various biomedical applications.

Acknowledgments

The authors would like to thank Naime Didem Kahya for her support in terms of the synthesis of the cobalt ferrite nanoparticles.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.